Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 29 citing Rosenstock: Advancing insulin therapy in type 2 diabetes previously treated with glargine.... (0.13 sec) 

Adjust to Target in Type 2 Diabetes


RM Bergenstal, M Johnson, MA Powers, A Wynne, … - Diabetes Care, 2008 - Am Diabetes Assoc
RESEARCH AND DESIGN METHODS—This 24-week, multicenter, randomized, controlled study compared two
algorithms for adjusting mealtime (glulisine) insulin along with a standard algorithm for adjusting
background (glargine) insulin in ...
Cited by 20 - Related articles - All 10 versions

Systematic review: comparative effectiveness and safety of premixed insulin …


R Qayyum, S Bolen, N Maruthur, L Feldman, … - Annals of Internal …, 2008 - Am Coll Physicians
Background: Evidence comparing premixed insulin analogues (a mixture of rapid-acting and
intermediate-acting insulin analogues) with other antidiabetic agents is urgently required to guide
appropriate therapy.
Cited by 20 - Related articles - All 8 versions

Long-acting insulin analogues versus NPH human insulin in type 2 diabetes A …


M Monami, N Marchionni, E Mannucci - Diabetes research and clinical practice, 2008 - Elsevier
A total of 14 RCTs was retrieved and included in the analysis. Long-acting analogues did not produce
any significant improvement of HbA1c, in comparison with NPH human insulin. When trials with
different analogues were analysed ...
Cited by 5 - Related articles - All 14 versions

[PDF] Estrategias de insulinización en la diabetes mellitus tipo 2


FJ Ampudia-Blasco, J Rosenstock - Avances en diabetología, 2008 - sediabetes.org
Resumen La diabetes tipo 2 se caracteriza por una resistencia a la insulina y un deterioro
progresivo de la función beta pancreática. Cuando dicha función se altera, muchos pacientes con
diabetes mellitus tipo 2 ne- ...
Cited by 4 - Related articles - View as HTML - All 6 versions

Three-year efficacy of complex insulin regimens in type 2 diabetes

- leicestershirediabetes.org.uk [PDF] 
RR Holman, AJ Farmer, MJ Davies, JC Levy, … - New England Journal …, 2009 - content.nejm.org
From the Diabetes Trials Unit (RRH, JLD, JFK, SKP), Oxford Centre for Diabetes, Endocrinology and
Metabo- lism (RRH, AJF, JCL, JLD, JFK, SKP), and the Department of Primary Health Care and National
Institute for Health Research ...
Cited by 2 - Related articles - All 8 versions

Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta- …


DS Lasserson, P Glasziou, R Perera, RR Holman, AJ … - Diabetologia, 2009 - Springer
Abstract Aims/hypothesis We compared the effect of biphasic, basal or prandial insulin regimens on
glucose control, clinical outcomes and adverse events in people with type 2 diabetes. Methods We
searched the Cochrane Library, ...
Cited by 2 - Related articles - All 2 versions

Insulin analogues: an example of applied medical science


B Sheldon, D Russell-Jones, J … - Diabetes, Obesity and …, 2009 - interscience.wiley.com
Insulin analogues were developed to try and achieve more physiological insulin replacement from
injection in the subcutaneous site. Their pharmacokinetics and pharmacodynamics differ from human
insulin when injected ...
Cited by 2 - Related articles - All 3 versions

Options for the intensification of insulin therapy when basal insulin is not enough in …


D Raccah - Diabetes, Obesity and Metabolism, 2008 - interscience.wiley.com
In the early treatment of type 2 diabetes mellitus (T2DM), the addition of a basal insulin, such as
insulin glargine, to existing oral therapy can help patients attain recommended glycaemic control
targets, including haemoglobin A 1c ...
Cited by 2 - Related articles - All 5 versions

The DURABLE trial study design: comparing the safety, efficacy, and durability of …


J Fahrbach, S Jacober, H Jiang, S Martin - 2008 - ncbi.nlm.nih.gov
The DURABLE (Assessing the DURAbility of Basal vs Lispro Mix 75/25 Insulin Efficacy) trial will
compare the ability of glargine once daily vs lispro mix 75/25 (75% insulin lispro protamine
suspension, 25% lispro) twice daily ...
Cited by 2

Insulin therapy in type 2 diabetes: what is the evidence?


MJP van Avendonk, G Rutten - Diabetes, Obesity and …, 2009 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets. In
this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the ...
Cited by 2 - Related articles - All 3 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google